These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14 related articles for article (PubMed ID: 1973894)
1. Characterization of the effects of omega-conotoxin GVIA on the responses of voltage-sensitive calcium channels. Keith RA; Mangano TJ; Pacheco MA; Salama AI J Auton Pharmacol; 1989 Aug; 9(4):243-52. PubMed ID: 2570074 [TBL] [Abstract][Full Text] [Related]
2. Voltage-dependent binding of 1,4-dihydropyridine Ca2+ channel antagonists and activators in cultured neonatal rat ventricular myocytes. Wei XY; Rutledge A; Triggle DJ Mol Pharmacol; 1989 Apr; 35(4):541-52. PubMed ID: 2539561 [TBL] [Abstract][Full Text] [Related]
3. Irreversible blockade of high-affinity choline uptake in rat brain by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ). Vickroy TW; Malphurs WL Biochem Pharmacol; 1994 Sep; 48(6):1281-7. PubMed ID: 7945422 [TBL] [Abstract][Full Text] [Related]
4. The pharmacological properties of the peptide, endothelin. Eglen RM; Michel AD; Sharif NA; Swank SR; Whiting RL Br J Pharmacol; 1989 Aug; 97(4):1297-307. PubMed ID: 2551446 [TBL] [Abstract][Full Text] [Related]
5. Behavioral and radioligand binding evidence for irreversible dopamine receptor blockade by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline. Hamblin MW; Creese I Life Sci; 1983 May; 32(19):2247-55. PubMed ID: 6133202 [TBL] [Abstract][Full Text] [Related]
6. Irreversible modification of the voltage-sensitive calcium channel by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ). Gopalakrishnan M; Triggle DJ Biochem Pharmacol; 1990 Jul; 40(2):327-32. PubMed ID: 1973894 [TBL] [Abstract][Full Text] [Related]